Add to Cart View Cart/Checkout More Products

Volume 16, 2012 CD

Six back issues of The International Journal of Pharmaceutical Compounding from 2012 on one convenient CD.
Only $95 per CD.
(Multiple Theme or Library CD orders priced at: 2 to 5 = $85; 6 to 9 = $75; 10 or more = $65 each.)

  • Permanant storage and easy retrieval of IJPC articles, formulations, SOP's and more.
  • Print IJPC articles in color for your marketing needs.

The back issues are stored as a high-resolution, full-color Adobe Portable Document Format (.pdf) file, complete with an electronic Table of Contents.

They may be searched by keyword and printed by the page. Software to read the PDF file is freely available from the Adobe Reader page.

Issues
Volume/IssueDateTitle
Vol. 16 No. 1 January/February 2012 Volume 16, Number 1
Vol. 16 No. 2 March/April 2012 Volume 16, Number 2
Vol. 16 No. 3 May/June 2012 Volume 16, Number 3
Vol. 16 No. 4 July/August 2012 Volume 16, Number 4
Vol. 16 No. 5 September/October 2012 Volume 16, Number 5
Vol. 16 No. 6 November/December 2012 Volume 16, Number 6

Articles
Volume/IssuePageTitle
Vol. 16 No. 1 4 PreScription: Fifteen Years and Counting
Vol. 16 No. 1 4 PreScription: The International Academy of Compounding Pharmacists Remembers Evelyn Timmons, RPh, FIACP, and George Roentsch, RPh, FIACP
Vol. 16 No. 1 6 Misinterpretation of United States Pharmacopeia Chapter <797>
Vol. 16 No. 1 12 Glutaraldehyde-treated Autologous Pericardium Used in Valve Repairs
Vol. 16 No. 1 17 Vitamins: Therapy or Hype
Vol. 16 No. 1 22 Oral Mucositis: Etiology and Clinical and Pharmaceutical Management
Vol. 16 No. 1 34 Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension
Vol. 16 No. 1 44 Case Studies of Compounded Tramadol Use in Cats
Vol. 16 No. 1 50 Legislative/Regulatory Update from the International Academy of Compounding Pharmacists
Vol. 16 No. 1 54 Institute for Safe Medication Practices Lifetime Achievement Award 2011
Vol. 16 No. 1 58 The ps in Therapeutics
Vol. 16 No. 1 62 The Use of Pluronic Lecithin Organogels in the Transdermal Delivery of Drugs
Vol. 16 No. 1 64 Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding–Nonsterile Preparations, Part 4
Vol. 16 No. 1 69 Calculations
Vol. 16 No. 1 70 Calcium Chloride 10% Injection
Vol. 16 No. 1 71 Calcium Gluconate 10% Injection
Vol. 16 No. 1 72 Magnesium Sulfate 10% Injection (0.8 mEq/mL)
Vol. 16 No. 1 73 Potassium Acetate 2-mEq/mL and 4-mEq/mL Injections
Vol. 16 No. 1 74 Potassium Phosphates Injection
Vol. 16 No. 1 75 Sodium Acetate 2-mEq/mL and 4-mEq/mL Injections
Vol. 16 No. 1 76 Sodium Bicarbonate 4.2%, 5.0%, 7.5%, and 8.4% Injections
Vol. 16 No. 1 77 Sodium Chloride 14.6% and 23.4% Injections
Vol. 16 No. 1 78 Sodium Phosphates Injection
Vol. 16 No. 1 79 Zinc 1-mg/mL and 5-mg/mL Injections
Vol. 16 No. 1 80 Chemical Stability of Pentoxifylline in a Topical Cream
Vol. 16 No. 1 82 Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration
Vol. 16 No. 1 86 PostScription: Best Practice Recommendations for Compounding 17-Hydroxyprogesterone
Vol. 16 No. 2 92 PreScription: Support the Organizations that Support You and Your Practice
Vol. 16 No. 2 92 PreScription: Pharmacy Compounding Accreditation Board: A Banner Year, More to Come
Vol. 16 No. 2 94 The International Academy of Compounding Pharmacists Stepping Up Efforts to Remedy Problems Caused by the U.S. Drug Enforcement Administration's "Constructive Transfer" Policy
Vol. 16 No. 2 98 Brazilian National System for the Monitoring and Improvement of Compounding Practices: Program Outcomes
Vol. 16 No. 2 104 Development of a Standardized Intranet Database of Formulation Records for Nonsterile Compounding, Part 2
Vol. 16 No. 2 110 Bilateral Areolar Hyperpigmentation Following Transdermal Administration of Compounded Hormone Replacement Therapy
Vol. 16 No. 2 117 Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum
Vol. 16 No. 2 125 A Concise Discussion of Headache Types, Part 1
Vol. 16 No. 2 134 Trade Shows: Planning Your Strategy
Vol. 16 No. 2 136 Quality Control: 5 Steps to Improve Quality in the Compounding Lab
Vol. 16 No. 2 146 Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 1
Vol. 16 No. 2 152 Calculations
Vol. 16 No. 2 154 Amiodarone Hydrochloride 50-mg/mL Injection
Vol. 16 No. 2 155 Bupivacaine Hydrochloride 0.5% with Epinephrine 1:200,000 Injection
Vol. 16 No. 2 156 Caffeine Citrate 20-mg/mL Injection
Vol. 16 No. 2 157 Chromium 4-mcg/mL Injection
Vol. 16 No. 2 158 Furosemide 10-mg/mL Injection
Vol. 16 No. 2 159 Glycopyrrolate 0.2-mg/mL Injection
Vol. 16 No. 2 160 Labetalol Hydrochloride 5-mg/mL Injection
Vol. 16 No. 2 161 Lorazepam 4-mg/mL Injection
Vol. 16 No. 2 162 Midazolam 5-mg/mL Injection
Vol. 16 No. 2 163 Promethazine Hydrochloride 50-mg/mL Injection
Vol. 16 No. 2 164 Stability of Omeprazole in SyrSpend SF Alka (Reconstituted)
Vol. 16 No. 2 167 Stability of Vancomycin in SyrSpend SF
Vol. 16 No. 2 170 Stability of Acetyl-L-carnitine in 5% Dextrose Using a High-Performance Liquid Chromatography–Mass Spectrometry Times 2 Method
Vol. 16 No. 2 174 PostScription: The Importance of Science in the Pharmacy Curriculum
Vol. 16 No. 3 180 PreScription: You're On Your Own
Vol. 16 No. 3 180 PreScription: Working in Handcuffs
Vol. 16 No. 3 182 A Concise Discussion of Headache Types, Part 2: Migraine
Vol. 16 No. 3 190 I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease
Vol. 16 No. 3 196 Burning Mouth Syndrome: A Discussion of a Complex Pathology
Vol. 16 No. 3 206 The Student Pharmacist Compounding Competition: Creating Problem Solvers
Vol. 16 No. 3 210 Treatment and Prevention of Insect Bites: Mosquitoes
Vol. 16 No. 3 220 Legislative/Regulatory Update from the International Academy of Compounding Pharmacists
Vol. 16 No. 3 224 Marketing: 16 Ways to Incorporate Facebook into Your Compounding Pharmacy
Vol. 16 No. 3 226 Quality Control: Analytical Methods: Why Do I Need a Certificate of Analysis?
Vol. 16 No. 3 230 Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 2: Documentation and Verification
Vol. 16 No. 3 236 Calculations
Vol. 16 No. 3 238 Acetazolamide 100-mg/mL Injection
Vol. 16 No. 3 239 Alfentanil 500-mcg/mL Injection
Vol. 16 No. 3 240 Ascorbic Acid 250-mg/mL Injection
Vol. 16 No. 3 241 Diltiazem Hydrochloride 5-mg/mL Injection
Vol. 16 No. 3 242 Famotidine 10-mg/mL Injection
Vol. 16 No. 3 243 Metoclopramide 5-mg/mL Injection
Vol. 16 No. 3 244 Naloxone Hydrochloride 1-mg/mL Injection
Vol. 16 No. 3 245 Orphenadrine Citrate 30-mg/mL Injection
Vol. 16 No. 3 246 Prochlorperazine 5-mg/mL Injection
Vol. 16 No. 3 247 Ranitidine 25-mg/mL Injection
Vol. 16 No. 3 248 In Vitro Percutaneous Absorption of Ketoprofen and Testosterone: Comparison of Pluronic Lecithin Organogel vs. Pentravan Cream
Vol. 16 No. 3 253 Compounding and Dispensing Errors Before and After Implementing Barcode Technology in a Nuclear Pharmacy
Vol. 16 No. 3 258 Influence of Temperature on the Thirty-Day Chemical Stability of Extemporaneously Prepared Dexamethasone Paste
Vol. 16 No. 3 262 PostScription: Rules for Pharmaceutically Elegant Calculations
Vol. 16 No. 4 268 PreScription: Lifelong Learning
Vol. 16 No. 4 268 PreScription: Drug Shortages and Discontinued Drugs
Vol. 16 No. 4 270 A Concise Discussion of Headache Types, Part 3: Migraine
Vol. 16 No. 4 276 Compounding Prokinetic Medications for Companion Animals
Vol. 16 No. 4 288 Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide
Vol. 16 No. 4 294 Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers
Vol. 16 No. 4 300 Legislative/Regulatory Update from the International Academy of Compounding Pharmacists
Vol. 16 No. 4 304 Selection of Color Additives: A Regulatory View
Vol. 16 No. 4 310 Okay, I've Got It: Now What Do I Do With It?
Vol. 16 No. 4 312 Quality Control: Glassware Washers: Cleaning Glassware and Implements Used in Compounding, Part 1
Vol. 16 No. 4 322 Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 3: Testing
Vol. 16 No. 4 330 Calculations
Vol. 16 No. 4 332 Betamethasone 0.6-mg/5-mL Syrup
Vol. 16 No. 4 333 Butorphanol Tartrate 2-mg/mL Injection
Vol. 16 No. 4 334 Diphenhydramine Hydrochloride 50-mg/mL Injection
Vol. 16 No. 4 335 Etomidate 2-mg/mL Injection
Vol. 16 No. 4 336 Foscarnet Sodium 24-mg/mL Injection
Vol. 16 No. 4 337 Ketorolac Tromethamine 15-mg/mL Injection
Vol. 16 No. 4 338 Methyldopate Hydrochloride 50-mg/mL Injection
Vol. 16 No. 4 339 Ondansetron Hydrochloride 2-mg/mL Injection
Vol. 16 No. 4 340 Sufentanil Citrate 50-mcg/mL Injection
Vol. 16 No. 4 341 Tobramycin 40-mg/mL Injection
Vol. 16 No. 4 342 Formulation and Stability Evaluation of Extemporaneously Prepared Atenolol Capsules from Crushed Atenolol Tablets
Vol. 16 No. 4 347 Stability of Gabapentin in SyrSpend SF
Vol. 16 No. 4 350 PostScription: Drug Shortages and Discontinued Drugs: Their Effects on Healthcare
Vol. 16 No. 5 356 PreScription: What Is Involved in the Making of Remington's?
Vol. 16 No. 5 358 Remington: The Science and Practice of Pharmacy: From the Past into the Future
Vol. 16 No. 5 364 Compounded Oral Ketamine for Severe Depression, Anxiety, and Pain in a Hospice Patient with End-stage Chronic Obstructive Pulmonary Disease, Cardiopulmonary Failure, and Severe Renal Insufficiency: A Case Report
Vol. 16 No. 5 369 Medical Therapy for Acquired Urinary Incontinence in Dogs
Vol. 16 No. 5 376 Bioidentical Thyroid Replacement Therapy in Practice: Delivering a Physiologic T4-T3 Ratio for Improved Patient Outcomes with the Listecki-Snyder Protocol
Vol. 16 No. 5 382 Legislative/Regulatory Update from the International Academy of Compounding Pharmacists
Vol. 16 No. 5 386 Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies
Vol. 16 No. 5 394 Marketing: Drug Shortages and Discontinued Drugs: Marketing Techniques that Compounding Pharmacists Can Use to Advise and Serve Their Patients
Vol. 16 No. 5 396 Quality Control: Glassware Washers: Cleaning Glassware and Implements Used in Compounding, Part 2
Vol. 16 No. 5 405 Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 4: Cleaning and Packaging
Vol. 16 No. 5 416 Calculations
Vol. 16 No. 5 418 Doxapram Hydrochloride 20-mg/mL injection
Vol. 16 No. 5 419 Enalaprilat 1.25-mg/mL Injection
Vol. 16 No. 5 420 Esmolol Hydrochloride 10-mg/mL Injection
Vol. 16 No. 5 421 Fluconazole 2-mg/mL Injection
Vol. 16 No. 5 422 Haloperidol 50-mg/mL in Oil Injection
Vol. 16 No. 5 423 Meperidine Hydrochloride 50-mg/mL Injection
Vol. 16 No. 5 424 Methocarbamol 100-mg/mL Injection
Vol. 16 No. 5 425 Metronidazole 5-mg/mL Injection
Vol. 16 No. 5 426 Nalbuphine Hydrochloride 10-mg/mL Injection
Vol. 16 No. 5 427 Oxymorphone Hydrochloride 1-mg/mL Injection
Vol. 16 No. 5 428 Evaluation of the Stability of Acetaminophen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-Use Date
Vol. 16 No. 5 431 Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time
Vol. 16 No. 5 434 Compounding of Slow-release Niacinamide Capsules: Feasibility and Characterization
Vol. 16 No. 5 438 PostScription: Remington Twenty-Second Edition
Vol. 16 No. 6 444 PreScription: A Degree in Pharmacy: How Valuable!
Vol. 16 No. 6 446 The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act
Vol. 16 No. 6 452 Palliative Care and Compounding for Household Pets
Vol. 16 No. 6 456 Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis
Vol. 16 No. 6 462 Recurrent Aphthous Stomatitis: Topical Treatment with Minocycline and Other Evidence-based Agents
Vol. 16 No. 6 471 Beyond-use Date: Establishment and Maintenance
Vol. 16 No. 6 476 Legislative/Regulatory Update from the International Academy of Compounding Pharmacists
Vol. 16 No. 6 480 Colds and Cough
Vol. 16 No. 6 484 Marketing: Overcoming Objections to Prescribing Compounded Medications
Vol. 16 No. 6 486 Quality Control: Analytical Methods. Certificates of Analysis, Part 1
Vol. 16 No. 6 490 Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 5: Outsourcing and Responsible Personnel
Vol. 16 No. 6 498 Calculations
Vol. 16 No. 6 500 Aminophylline 25-mg/mL Injection
Vol. 16 No. 6 501 Ammonium Chloride 5-mEq/mL Injection
Vol. 16 No. 6 502 Azathioprine 10-mg/mL Injection
Vol. 16 No. 6 503 Copper 0.4-mg/mL Injection
Vol. 16 No. 6 504 Dipyridamole 5-mg/mL Injection
Vol. 16 No. 6 505 Dopamine Hydrochloride 80-mg/mL Injection
Vol. 16 No. 6 506 Ergotamine Tartrate 1-mg and Caffeine 100-mg Capsules
Vol. 16 No. 6 507 Papaverine Hydrochloride 30-mg/mL Injection
Vol. 16 No. 6 508 Valproate Sodium 100-mg/mL Injection
Vol. 16 No. 6 509 Vercuronium Bromide 1-mg/mL Injection
Vol. 16 No. 6 510 Stability of Ursodiol in SyrSpend SF Cherry Flavored
Vol. 16 No. 6 513 Stability of Propranolol Hydrochloride in SyrSpend SF
Vol. 16 No. 6 516 Rice Bran Oil: Preparation and Evaluation of Novel Liquisolid and Semisolid Formulations
Vol. 16 No. 6 524 PostScription: Center for Compounding Practice and Research Underway at Virginia Commonwealth University School of Pharmacy